Insider · CIK 0001494695

Manning Paul B

Reports to the SEC for 9 companies · NEEDHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001494695

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-30	CADLCandel Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+2,189 sh	$8.68	+$19K	2,189
2026-06-30	CADLCandel Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+2,199 sh	$8.64	+$19K	2,199
2026-06-23	CADLCandel Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+32K sh	—	—	32,000
2026-06-16	LQDALiquidia CorpA Award	Director	AAward	+5,882 sh	—	—	475,465
2026-06-04	LQDALiquidia CorpS Sale	Director	SSale	−68.3K sh	$63.83	−$4.36M	810,945
2026-06-04	LQDALiquidia CorpS Sale	Director	SSale	−11.5K sh	$63.13	−$727K	804,798
2026-06-04	LQDALiquidia CorpS Sale	Director	SSale	−12.6K sh	$64.42	−$812K	798,335
2026-06-04	LQDALiquidia CorpS Sale	Director	SSale	−19.1K sh	$62.62	−$1.2M	879,210
2026-06-04	LQDALiquidia CorpS Sale	Director	SSale	−88.5K sh	$64.28	−$5.69M	716,311
2026-03-31	CADLCandel Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+4,618 sh	$4.11	+$19K	4,618
2026-02-23	CADLCandel Therapeutics, Inc.P Purchase	Director	PPurchase	+550K sh	$5.45	+$3M	2,763,527
2026-02-11	LQDALiquidia CorpJ Other	Director	JOther	+55.1K sh	$42.63	+$2.35M	469,583
2026-02-11	LQDALiquidia CorpJ Other	Director	JOther	−55.1K sh	$42.63	−$2.35M	0
2025-11-25	VRCAVerrica Pharmaceuticals Inc.P Purchase	Director, 10% Owner	PPurchase	+1.38M sh	$4.24	+$5.84M	3,958,189
2025-11-25	VRCAVerrica Pharmaceuticals Inc.P Purchase	Director, 10% Owner	PPurchase	+2.75M sh	$4.24	+$11.7M	3,348,372
2025-11-25	VRCAVerrica Pharmaceuticals Inc. · Series C Warrant (right to buy)P Purchase	Director, 10% Owner	PPurchase	+688K sh	—	—	687,690
2025-11-25	VRCAVerrica Pharmaceuticals Inc. · Series C Warrant (right to buy)P Purchase	Director, 10% Owner	PPurchase	+344K sh	—	—	343,845
2025-09-02	LQDALiquidia CorpS Sale	Director	SSale	−74.2K sh	$29.14	−$2.16M	430,828
2025-09-02	LQDALiquidia CorpS Sale	Director	SSale	−254K sh	$28.67	−$7.28M	505,058
2025-08-29	LQDALiquidia CorpS Sale	Director	SSale	−188K sh	$27.62	−$5.2M	759,096
2025-08-28	LQDALiquidia CorpS Sale	Director	SSale	−154K sh	$27.94	−$4.31M	947,328
2025-06-25	CADLCandel Therapeutics, Inc.A Award	Director	AAward	+1.07M sh	$4.67	+$5M	2,213,069
2025-06-17	CADLCandel Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+14.2K sh	—	—	14,240
2025-06-17	LQDALiquidia CorpA Award	Director	AAward	+18.4K sh	—	—	38,755
2025-05-30	TSHATaysha Gene Therapies, Inc.P Purchase	10% Owner	PPurchase	+750K sh	$2.75	+$2.06M	2,841,704
2024-12-16	CADLCandel Therapeutics, Inc.P Purchase	Director	PPurchase	+750K sh	$6.00	+$4.5M	1,303,752
2024-12-16	CADLCandel Therapeutics, Inc.P Purchase	Director	PPurchase	+500K sh	$6.00	+$3M	1,142,406
2024-11-26	VRCAVerrica Pharmaceuticals Inc.G Gift	Director, 10% Owner	GGift	−450K sh	—	—	25,828,094
2024-11-22	VRCAVerrica Pharmaceuticals Inc. · Series B Warrants (right to buy)P Purchase	Director, 10% Owner	PPurchase	+2.25M sh	—	—	2,247,191
2024-11-22	VRCAVerrica Pharmaceuticals Inc. · Series A Warrants (right to buy)P Purchase	Director, 10% Owner	PPurchase	+2.25M sh	—	—	2,247,191
2024-11-22	VRCAVerrica Pharmaceuticals Inc. · Series B Warrants (right to buy)P Purchase	Director, 10% Owner	PPurchase	+9.21M sh	—	—	9,213,483
2024-11-22	VRCAVerrica Pharmaceuticals Inc. · Series A Warrants (right to buy)P Purchase	Director, 10% Owner	PPurchase	+9.21M sh	—	—	9,213,483
2024-11-22	VRCAVerrica Pharmaceuticals Inc.P Purchase	Director, 10% Owner	PPurchase	+4.49M sh	—	—	5,976,101
2024-11-22	VRCAVerrica Pharmaceuticals Inc.P Purchase	Director, 10% Owner	PPurchase	+18.4M sh	—	—	26,278,094
2024-09-19	VRCAVerrica Pharmaceuticals Inc.G Gift	Director, 10% Owner	GGift	+892K sh	—	—	891,870.42
2024-09-19	VRCAVerrica Pharmaceuticals Inc.G Gift	Director, 10% Owner	GGift	−2.68M sh	—	—	0
2024-09-19	VRCAVerrica Pharmaceuticals Inc.G Gift	Director, 10% Owner	GGift	+892K sh	—	—	891,870.41
2024-09-19	VRCAVerrica Pharmaceuticals Inc.G Gift	Director, 10% Owner	GGift	+892K sh	—	—	891,870.42
2024-09-12	LQDALiquidia CorpP Purchase	Director	PPurchase	+337K sh	$8.90	+$3M	816,311
2024-06-27	TSHATaysha Gene Therapies, Inc.P Purchase	10% Owner	PPurchase	+1.33M sh	$2.25	+$3M	1,333,333
2024-06-26	CADLCandel Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+14.2K sh	—	—	14,240
2024-06-20	LQDALiquidia CorpA Award	Director	AAward	+20.4K sh	—	—	299,689
2023-12-14	LQDALiquidia CorpP Purchase	Director	PPurchase	+279K sh	$7.16	+$2M	279,330
2023-11-17	TSHATaysha Gene Therapies, Inc.P Purchase	10% Owner	PPurchase	+100K sh	$1.63	+$163K	16,566,667
2023-08-16	TSHATaysha Gene Therapies, Inc.P Purchase	10% Owner	PPurchase	+16.5M sh	$0.90	+$14.8M	16,466,667
2023-07-24	VRCAVerrica Pharmaceuticals Inc.P Purchase	Director, 10% Owner	PPurchase	+200K sh	$5.02	+$1M	7,851,128
2023-06-28	CADLCandel Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+14.2K sh	—	—	14,240
2023-06-19	LQDALiquidia Corp · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2022-10-31	TSHATaysha Gene Therapies, Inc.P Purchase	10% Owner	PPurchase	+1.5M sh	$2.00	+$3M	1,642,202
2022-10-13	CADLCandel Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+14.2K sh	—	—	14,240

Recent filings

Accepted (ET)
Oct 24
Manning Paul B0001193125-26-412654
SEC(opens sec.gov)
Jul 14
Manning Paul B0001494695-26-000018
SEC(opens sec.gov)
Jun 244
Manning Paul B0001494695-26-000015
SEC(opens sec.gov)
Jun 184
Manning Paul B0001494695-26-000013
SEC(opens sec.gov)
Jun 84
Manning Paul B0001494695-26-000011
SEC(opens sec.gov)
Apr 24
Manning Paul B0001494695-26-000007
SEC(opens sec.gov)
Feb 264
Manning Paul B0001193125-26-078246
SEC(opens sec.gov)
Feb 124
Manning Paul B0001494695-26-000002
SEC(opens sec.gov)
Nov 254
Manning Paul B0001494695-25-000004
SEC(opens sec.gov)
Sep 24
Manning Paul B0001415889-25-023468
SEC(opens sec.gov)

Companies

Address

C/O CANDEL THERAPEUTICS, INC. 117 KENDRICK ST., SUITE 450

NEEDHAM, MA, 02494